Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Seelos Therapeutics, Inc. SEEL

Full chart Compare
Set alert

Price alert · SEEL

All alert types
0.37 USD 0.00 (+0.00%)

Nov 18, 2024, 3:58 PM EST

0.37 Day range 0.37

52-week range unavailable

YTD
-71.09%
1 year
-71.09%

Financial health

Altman Z-Score

-156.64 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -23.0×
FY 2014: -6982×FY 2015: -10538×FY 2016: -2222×FY 2017: 142261×FY 2018: -516×FY 2019: -69.1×FY 2020: -471×FY 2021: -281×FY 2022: -121×FY 2023: -23.0×
FY 2014 5y median -121× FY 2023
P/S 396×
FY 2014: 16429×FY 2015: 41429×FY 2016: 2865×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 9289×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 396×
FY 2014 5y median 0.0× FY 2023
P/B -26.0×
FY 2014: 79267×FY 2015: -20161×FY 2016: -2197×FY 2017: 10451×FY 2018: 1853×FY 2019: -497624×FY 2020: 3520×FY 2021: 331×FY 2022: -871×FY 2023: -26.0×
FY 2014 5y median -26.0× FY 2023
P/FCF -36.5×
FY 2014: -8180×FY 2015: -8724×FY 2016: -1262×FY 2017: -4365×FY 2018: -586×FY 2019: -180×FY 2020: -433×FY 2021: -387×FY 2022: -150×FY 2023: -36.5×
FY 2014 5y median -180× FY 2023
EV/EBITDA -23.4×
FY 2014: -6924×FY 2015: -11245×FY 2016: -2704×FY 2017: -4327×FY 2018: -1516×FY 2019: -125×FY 2020: -482×FY 2021: -301×FY 2022: -126×FY 2023: -23.4×
FY 2014 5y median -126× FY 2023
EV/Sales 401×
FY 2014: 16428×FY 2015: 41431×FY 2016: 2866×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 9262×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 401×
FY 2014 5y median 0.0× FY 2023
FCF Yield -2.7%
FY 2014: -0.0%FY 2015: -0.0%FY 2016: -0.1%FY 2017: -0.0%FY 2018: -0.2%FY 2019: -0.6%FY 2020: -0.2%FY 2021: -0.3%FY 2022: -0.7%FY 2023: -2.7%
FY 2014 5y median -0.6% FY 2023

Profitability

Gross Margin -1267.1%
FY 2014: 90.1%FY 2015: 80.9%FY 2016: 32.5%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -5916.8%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -1267.1%
FY 2014 5y median 0.0% FY 2023
Operating Margin -1838.4%
FY 2014: -243.6%FY 2015: -441.2%FY 2016: -232.6%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -7932.5%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -1838.4%
FY 2014 5y median 0.0% FY 2023
Net Margin -1719.6%
FY 2014: -235.3%FY 2015: -393.1%FY 2016: -129.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -13435.5%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -1719.6%
FY 2014 5y median 0.0% FY 2023
ROE 113.0%
FY 2014: -1135.3%FY 2015: 191.3%FY 2016: 98.9%FY 2017: 7.3%FY 2018: -359.3%FY 2019: 719757.1%FY 2020: -747.3%FY 2021: -117.8%FY 2022: 717.5%FY 2023: 113.0%
FY 2014 5y median 113.0% FY 2023
ROIC 210.0%
FY 2014: -617.0%FY 2015: -1358.1%FY 2016: -23941.1%FY 2017: -208.4%FY 2018: -180.5%FY 2019: -9354.4%FY 2020: -150.1%FY 2021: -80.8%FY 2022: -741.1%FY 2023: 210.0%
FY 2014 5y median -150.1% FY 2023
ROA -699.2%
FY 2014: -147.1%FY 2015: -242.2%FY 2016: -158.1%FY 2017: 4.8%FY 2018: -245.8%FY 2019: -454.1%FY 2020: -109.9%FY 2021: -80.9%FY 2022: -334.7%FY 2023: -699.2%
FY 2014 5y median -334.7% FY 2023

Growth (YoY)

Revenue 0.0%
FY 2014: 268.7%FY 2015: -47.7%FY 2016: 19.1%FY 2017: -100.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -100.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 FY 2023
Operating Income 42.9%
FY 2014: -29.9%FY 2015: 5.4%FY 2016: 37.2%FY 2017: 20.4%FY 2018: 14.3%FY 2019: -225.2%FY 2020: 36.9%FY 2021: -228.7%FY 2022: -15.0%FY 2023: 42.9%
FY 2014 FY 2023
EPS (diluted) 64.0%
FY 2014: -11.7%FY 2015: 35.0%FY 2016: 37.1%FY 2017: 102.2%FY 2018: -2977.9%FY 2019: -73.6%FY 2020: 82.7%FY 2021: -73.1%FY 2022: 3.6%FY 2023: 64.0%
FY 2014 FY 2023
Free Cash Flow 61.2%
FY 2014: -18.9%FY 2015: -23.6%FY 2016: 43.1%FY 2017: 20.0%FY 2018: 22.3%FY 2019: -137.5%FY 2020: -8.3%FY 2021: -134.3%FY 2022: -25.7%FY 2023: 61.2%
FY 2014 FY 2023

Financial Health

Current Ratio 0.1×
FY 2014: 1.2×FY 2015: 0.4×FY 2016: 0.3×FY 2017: 4.2×FY 2018: 3.1×FY 2019: 1.0×FY 2020: 2.4×FY 2021: 10.1×FY 2022: 0.9×FY 2023: 0.1×
FY 2014 5y median 1.0× FY 2023
Quick Ratio 0.1×
FY 2014: 1.2×FY 2015: 0.4×FY 2016: 0.3×FY 2017: 4.2×FY 2018: 3.1×FY 2019: 1.0×FY 2020: 2.4×FY 2021: 10.1×FY 2022: 0.9×FY 2023: 0.1×
FY 2014 5y median 1.0× FY 2023
Debt / Equity -0.4×
FY 2014: 2.5×FY 2015: -1.0×FY 2016: -0.9×FY 2017: 0.0×FY 2018: 0.9×FY 2019: 0.0×FY 2020: 3.8×FY 2021: 0.3×FY 2022: -1.9×FY 2023: -0.4×
FY 2014 5y median 0.0× FY 2023
Net Debt / EBITDA -0.3×
FY 2014: 0.3×FY 2015: -0.3×FY 2016: -0.7×FY 2017: 0.6×FY 2018: 0.4×FY 2019: 0.4×FY 2020: 0.3×FY 2021: 1.0×FY 2022: -0.1×FY 2023: -0.3×
FY 2014 5y median 0.3× FY 2023
Interest Coverage -540×
FY 2014: -66.5×FY 2015: -25.3×FY 2016: -13.1×FY 2017: -129×FY 2018: 0.0×FY 2019: -1026×FY 2020: -114×FY 2021: -38.6×FY 2022: -5065×FY 2023: -540×
FY 2014 5y median -540× FY 2023

Dividends

Dividend Yield 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31